These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30545831)

  • 41. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
    Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
    Dow N; Coleman JR; Moore H; Osborn ZT; Sackheim AM; Hennig G; Butenas S; Nelson MT; Moore EE; Freeman K
    J Trauma Acute Care Surg; 2020 Feb; 88(2):258-265. PubMed ID: 31999655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
    Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.
    Morrow GB; Feller T; McQuilten Z; Wake E; Ariëns RAS; Winearls J; Mutch NJ; Laffan MA; Curry N
    Crit Care; 2022 Sep; 26(1):290. PubMed ID: 36163263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
    Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
    Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
    Gaule TG; Ajjan RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Importance of the structure of the clot in thrombolysis].
    Soria C; Soria J; Mirshahi M; Desvignes P; Bonnet P; Caen JP
    Ann Biol Clin (Paris); 1987; 45(2):207-11. PubMed ID: 2441630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis.
    Sidelmann JJ; Gram JB; Rasmussen JJ; Kistorp C
    Semin Thromb Hemost; 2021 Feb; 47(1):11-17. PubMed ID: 33017849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.
    Zamolodchikov D; Strickland S
    Blood; 2012 Apr; 119(14):3342-51. PubMed ID: 22238323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
    Bryk AH; Natorska J; Ząbczyk M; Zettl K; Wiśniewski JR; Undas A
    J Proteomics; 2020 Oct; 229():103946. PubMed ID: 32810596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lytic resistance of fibrin containing red blood cells.
    Wohner N; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2306-13. PubMed ID: 21737785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
    Nogami K; Matsumoto T; Sasai K; Ogiwara K; Arai N; Shima M
    Br J Haematol; 2019 Nov; 187(4):518-529. PubMed ID: 31335970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.